ConductScience.org, home

Paper30879080

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.

Ozen S and 19 others. Rheumatology (Oxford), 2019. Cited by 223 papers, by iCite.

Cite this record

ConductScience Library. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Papers, record 30879080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30879080

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
PubMed
Journal
Rheumatology (Oxford)
PubMed
Year
2019
PubMed
Publication types
Consensus Statement, Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
223
iCite
Relative citation ratio, by iCite
14.1
iCite
Revised in PubMed
2026-01-27
PubMed

Authors20

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ozen SSeza
2Marks SDStephen D
3Brogan PPaul
4Groot NNoortje
5de Graeff NNienke
6Avcin TTadej
7Bader-Meunier BBrigitte
8Dolezalova PPavla
9Feldman BMBrian M
10Kone-Paut IIsabelle
11Lahdenne PPekka
12McCann LLiza
13Pilkington CClarissa
14Ravelli AAngelo
15van Royen AAnnet
16Uziel YYosef
17Vastert BBas
18Wulffraat NNico
19Kamphuis SSylvia
20Beresford MWMichael W

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
IgA VasculitisMajor topic
Immunoglobulin AMajor topic
Analgesia
Angiotensin-Converting Enzyme Inhibitors
Biopsy
Child
Evidence-Based Medicine
Gastrointestinal Diseases
Glomerulonephritis, IGA
Glucocorticoids
Humans
Kidney
Severity of Illness Index
Skin

Source PubMed

Download CSV of topics

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in31170291Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis - the SHARE initiative.https://conductscience.org/library/papers/31170291PubMed
Comment in31243449Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.https://conductscience.org/library/papers/31243449PubMed
Comment in32337557Comment on: European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.https://conductscience.org/library/papers/32337557PubMed

Download CSV of comments and corrections

Cited by156

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 223 citations.

PMIDTitleJournalYearIn PapersSource
42972284Association between the time window of rash recurrence and the risk of renal involvement within 6 months in children with immunoglobulin A vasculitis.BMC Pediatr2026https://conductscience.org/library/papers/42972284PubMed
42953036Coagulation and fibrinolysis biomarkers associated with gastrointestinal bleeding in children with immunoglobulin A vasculitis: a retrospective cohort study.Front Pediatr2026https://conductscience.org/library/papers/42953036PubMed
42819322
Addition of telitacicept to glucocorticoid reduces abdominal pain duration and relapse rate in children with severe abdominal Henoch-Schönlein purpura: a single-center retrospective matched cohort study.
Front Immunol2026https://conductscience.org/library/papers/42819322PubMed
42799772Infectious triggers in IgA vasculitis in children: current evidence, causal attribution and immunopathogenic mechanisms.Rheumatol Int2026https://conductscience.org/library/papers/42799772PubMed
42723862Integrated untargeted and targeted metabolomics combined with experimental validation reveal glutathione-related oxidative stress in pediatric IgA vasculitis nephritis.Front Pharmacol2026https://conductscience.org/library/papers/42723862PubMed
42647384Cutaneous Pediatric Vasculitis: A Clinico-Histopathological Overview of Common and Novel Entities.Dermatopathology (Basel)2026https://conductscience.org/library/papers/42647384PubMed
42634084Profiling immune cell subsets in pediatric IgA vasculitis and immune thrombocytopenia: insights into disease pathogenesis and clinical correlates.Pediatr Res2026https://conductscience.org/library/papers/42634084PubMed
42489915Patterns of kidney involvement after corticosteroid treatment for extrarenal symptoms in pediatric IgA vasculitis (Henoch-Schönlein Purpura): phenotypes and outcomes.Pediatr Nephrol2026https://conductscience.org/library/papers/42489915PubMed
42373959Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis.Pediatr Nephrol2026https://conductscience.org/library/papers/42373959PubMed
42289526Factors predicting the severity of gastrointestinal involvement in children with IgA vasculitis? A Turkish multicenter cohort study.Eur J Pediatr2026https://conductscience.org/library/papers/42289526PubMed
42260845Efficacy and safety of traditional Chinese medicine in treating pediatric IgA vasculitis nephritis: A systematic review and meta-analysis of randomized controlled trials.Medicine (Baltimore)2026https://conductscience.org/library/papers/42260845PubMed
42220508Diagnostic value of inflammatory biomarkers of IgA vasculitis based on Olink technology.Front Immunol2026https://conductscience.org/library/papers/42220508PubMed
42187213Risk factors and critical thresholds for glucocorticoid-induced ocular adverse reactions in children: implications for muscle and neuromuscular disease management.Eur J Transl Myol2026https://conductscience.org/library/papers/42187213PubMed
42182938The ratio of TG/CysC is a significant indicator of nephritis in children with IgA vasculitis.J Clin Biochem Nutr2026https://conductscience.org/library/papers/42182938PubMed
42018240Clinical practice guideline for pediatric IgA vasculitis in Japan 2023: a digest-secondary publication.Clin Exp Nephrol2026https://conductscience.org/library/papers/42018240PubMed
41780977IgA Vasculitis Developing during Trastuzumab Emtansine Therapy for HER2-positive Breast Cancer.Intern Med2026https://conductscience.org/library/papers/41780977PubMed
41680872Prolonged skin involvement distinguishes adolescent from childhood-onset IgA vasculitis: a large multicenter study with 687 patients.Adv Rheumatol2026https://conductscience.org/library/papers/41680872PubMed
41568275A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop.Kidney Int Rep2026https://conductscience.org/library/papers/41568275PubMed
41562803An 8-Year-Old Female with Giardiasis-Associated Henoch-Schönlein Purpura: A Case Report and Literature Review.Reports (MDPI)2025https://conductscience.org/library/papers/41562803PubMed
41502882Optimal drug treatment for children with IgA vasculitis nephritis: a systematic review and network meta-analysis.Transl Pediatr2025https://conductscience.org/library/papers/41502882PubMed

See all 156 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30879080

GET https://conductscience.org/api/papers/v1/30879080/cited_by?page=2